Gain Therapeutics Inc.

NASDAQ: GANX · Real-Time Price · USD
1.73
0.19 (12.34%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:49 PM EDT

Gain Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-18.59M -20.93M -20.41M -21.37M -21.6M -21.14M -22.27M -22.22M -22.06M -19.46M -17.59M -16.14M -16.24M -14.71M -13.89M -12.33M -8.46M -5.44M
Depreciation & Amortization
85.94K 84.2K 84.07K 86.35K 85.22K 84.86K 83.58K 78.1K 75.42K 75.2K 64.17K 51.85K 38.15K 20.29K 15.48K 12.53K 10.78K 10.89K
Stock-Based Compensation
1.66M 2.62M 2.39M 2.59M 3.14M 2.88M 3.26M 3.26M 2.71M 1.79M 1.53M 1.25M 1.15M 1.04M 839.37K 630.54K 383.93K 192.37K
Other Working Capital
-1.59M -2.02M -1.36M -1.19M -1.08M 1.4M 1.09M 2.29M 2.88M 927.79K 448.15K -451.16K -1.1M -1.01M 34.7K 78.86K 16.57K -121.15K
Other Non-Cash Items
9.86M 453.26K 143.52K 1.03M 905.94K 1.12M 1.2M -388.46K -253.19K -375.4K -206.86K -72.97K -57.36K 356.83K 332.39K 348.18K 368.42K 30.57K
Deferred Income Tax
n/a n/a n/a -1.58M -1.58M -1.58M -1.58M n/a n/a n/a n/a 227.66K 744.66K 744.66K 744.66K 517K n/a n/a
Change in Working Capital
-2.55M -1.34M -1.08M -1.84M 81.58K 401.57K 442.23K 2.16M 3.09M 1.51M 1.51M -258.22K 529.75K 552.67K -385.11K 1.31M -453.56K -355.15K
Operating Cash Flow
-9.53M -19.11M -18.87M -21.08M -18.97M -18.24M -18.87M -17.11M -16.43M -16.46M -14.69M -14.93M -13.84M -12M -12.37M -9.53M -8.09M -5.3M
Capital Expenditures
-945 -22.49K -22.49K -21.56K -22.21K -4.31K -15.36K -24.74K -81.27K -122.17K -118.95K -120.65K -95.6K -73.55K -94.21K -97.67K -66.96K -44.42K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a 1M n/a n/a n/a -1M n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a -1.96M -3.89M -4.85M -19.69M -17.74M -15.8M -14.84M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
-42.5K 1.98M 5M 8.18M 10.11M 11.14M 12.19M 11.13M 10.2M 7.15M 3.08M 1M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a -1M n/a n/a n/a 1M n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-43.45K 1.96M 4.98M 8.16M 10.09M 11.13M 10.22M 7.21M 5.27M -12.66M -14.77M -14.92M -14.94M -73.55K -94.21K -97.67K -66.96K -44.42K
Debt Repayment
-68.14K -90.25K -90.88K -90.68K -90.19K -90.33K -89.07K -88.07K -86.02K -62.41K -78.77K -79.14K -58.56K -59.92K -21.95K 30.4K 453.68K 453.68K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.68M 229.85K -51.01K -51.01K -267.29K 1.94M 2.22M 2.22M 2.22M n/a n/a 12.22K 12.22K -201.58K -841.27K -1.32M 7.8M 8M
Financial Cash Flow
7.99M 15.55M 13.01M 20.26M 19.59M 11.75M 12.64M 3.06M 2.9M 708.11K -78.77K -66.93K -46.35K -261.5K 41.77M 41.34M 50.88M 51.08M
Net Cash Flow
-10.24M -1.57M -1.41M 7.78M 10.62M 4.65M 4.48M -6.61M -7.98M -28.35M -29.57M -30.11M -28.87M -12.27M 29.41M 31.74M 42.69M 45.69M
Free Cash Flow
-9.53M -19.13M -18.9M -21.1M -18.99M -18.24M -18.88M -17.13M -16.51M -16.58M -14.81M -15.05M -13.93M -12.08M -12.46M -9.63M -8.16M -5.34M